Plasbumin-5 Market Report 2026

Plasbumin-5 Market Overview

• The Plasbumin-5 market growth in the historic period has been driven by increasing incidence of hypovolemia and shock cases, expansion of critical care infrastructure • Market expansion is supported by increasing demand for advanced plasma-derived therapies, rising focus on patient blood management • Growth Driver: Rising Surgical Procedures Driving Growth In The Plasbumin-5 Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Plasbumin-5 Market?

Plasbumin-5 is a sterile, human plasma-derived albumin solution designed to act as a volume expander for patients experiencing significant fluid loss. This highly purified therapy helps restore blood volume, stabilize blood pressure, and enhance the transport of vital substances throughout the body. The main types of plasbumin-5 formulations are liquid and lyophilized (powder). Liquid Plasbumin-5 is a ready-to-use intravenous albumin solution, designed for rapid administration in emergency or clinical settings to quickly replenish albumin levels in patients. It is packaged in various packaging sizes, such as 50 milliliters (mL), 250 milliliters (mL), and 500 milliliters (mL), for several clinical indications, including hypovolemia shock, hypoproteinemia, acute respiratory distress syndrome (ARDS), cardiopulmonary bypass surgery, and acute liver failure. It is distributed through various distribution channels, such as hospitals and clinics and retail and specialty pharmacies, and used by several end-users, including adult patients and geriatric patients.

What Is The Plasbumin-5 Market Growth Forecast?

The growth in the forecast period can be attributed to increasing demand for advanced plasma-derived therapies, rising focus on patient blood management, expansion of icu capacity globally, growing adoption in liver and cardiac care, increasing investments in plasma collection infrastructure. Major trends in the forecast period include increasing use of plasma-derived volume expanders, rising demand for critical care albumin therapy, growing adoption in surgical and icu settings, expansion of high-purity albumin solutions, enhanced focus on hemodynamic stabilization.

Global Plasbumin-5 Market Segmentation

1) By Formulation: Liquid, Lyophilized (Powder) 2) By Packaging Size: 50 Milliliter (mL), 250 Milliliter (mL), 500 Milliliter (mL) 3) By Clinical Indication: Hypovolemia Shock, Hypoproteinemia, Acute Respiratory Distress Syndrome (ARDS), Cardiopulmonary Bypass Surgery, Acute Liver Failure 4) By Distribution Channel: Hospital And Clinics, Retail And Specialty Pharmacies 5) By End-User: Adult Patients, Geriatric Patients

What Are The Drivers Of The Plasbumin-5 Market?

The rising surgical procedures are expected to propel the growth of the plasbumin-5 market going forward. Surgical procedures are driven by advancements in medical technology, increased healthcare access, and a growing demand for cosmetic and corrective treatments. Plasbumin-5 acts as a volume expander, maintaining blood volume, blood pressure, and tissue perfusion, especially in cases of surgery. It also helps manage hypoproteinemia and supports recovery and healing post-surgery. For instance, in April 2025, according to the British Association of Aesthetic Plastic Surgeons, a UK-based surgical organization, 27,462 cosmetic surgeries took place in 2024 in the UK, marking a notable 5% overall rise. Therefore, the rising surgical procedures are driving the growth of the plasbium-5 market. The rising incidence of burn injuries is expected to propel the growth of the plasbumin-5 market going forward. Burn injuries are damage to the skin or underlying tissues caused by heat, chemicals, electricity, radiation, or friction. Some factors responsible for burn injuries include heat exposure, household accidents, and workplace hazards. Plasbumin-5 helps restore blood volume, maintain circulatory pressure, and improve protein levels, supporting fluid balance and tissue repair in burn injuries. It prevents edema, reduces shock risk, and promotes faster recovery by maintaining osmotic pressure. For instance, in August 2024, according to a report by the American Burn Association, a US-based organization focused on burn-related research, rehabilitation, and prevention, there were 32,540 cases in 2023 compared to 30,135 burn cases in 2022, contributing to a total of 156,073 cases over five years. Therefore, the rising incidence of burn injuries is driving the growth of the plasbium-5 market.

Key Players In The Global Plasbumin-5 Market

Major companies operating in the plasbumin-5 market are Grifols Therapeutics LLC

What Are Latest Mergers And Acquisitions In The Plasbumin-5 Market?

In December 2023, Grifols, a Spain-based provider of plasma-derived medicines, partnered with Haier Group through Shanghai RAAS (SRAAS) to expand the distribution of human serum albumin 5% (Plasbumin 5) in China. Through this collaboration, the companies aim to secure long-term albumin supply, extend exclusive distribution agreements, and meet growing demand for plasma-derived therapies. This partnership underscores the Plasbumin 5 market’s focus on strengthening regional supply chains and ensuring consistent access to high-quality albumin products. Haier Group through Shanghai RAAS (SRAAS), a China-based provider of plasma and hemoderivative solutions.

Regional Insights

North America was the largest region in the plasbumin-5 market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Plasbumin-5 Market?

The plasbumin-5 market consists of sales of human albumin intravenous solutions, sterile, and ready-to-use vials. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Plasbumin-5 Market Report 2026?

The plasbumin-5 market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the plasbumin-5 industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.